These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 29705213

  • 1. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
    García MC, Martinelli M, Ponce NE, Sanmarco LM, Aoki MP, Manzo RH, Jimenez-Kairuz AF.
    Eur J Pharm Sci; 2018 Jul 30; 120():107-122. PubMed ID: 29705213
    [Abstract] [Full Text] [Related]

  • 2. Polysaccharides-based multiparticulated interpolyelectrolyte complexes for controlled benznidazole release.
    García MC, Manzo RH, Jimenez-Kairuz A.
    Int J Pharm; 2018 Jul 10; 545(1-2):366-377. PubMed ID: 29747000
    [Abstract] [Full Text] [Related]

  • 3. Improved efficacy and safety of low doses of benznidazole-loaded multiparticulate delivery systems in experimental Chagas disease therapy.
    García MC, Eberhardt N, Sanmarco LM, Ponce NE, Jimenez-Kairuz AF, Aoki MP.
    Eur J Pharm Sci; 2021 Sep 01; 164():105912. PubMed ID: 34133985
    [Abstract] [Full Text] [Related]

  • 4. Preclinical pharmacokinetics of benznidazole-loaded interpolyelectrolyte complex-based delivery systems.
    García MC, Guzman ML, Himelfarb MA, Litterio NJ, Olivera ME, Jimenez-Kairuz A.
    Eur J Pharm Sci; 2018 Sep 15; 122():281-291. PubMed ID: 30018011
    [Abstract] [Full Text] [Related]

  • 5. Benznidazole self-emulsifying delivery system: A novel alternative dosage form for Chagas disease treatment.
    Mazzeti AL, Oliveira LT, Gonçalves KR, Schaun GC, Mosqueira VCF, Bahia MT.
    Eur J Pharm Sci; 2020 Mar 30; 145():105234. PubMed ID: 31978590
    [Abstract] [Full Text] [Related]

  • 6. 3D printed benznidazole tablets based on an interpolyelectrolyte complex by melting solidification printing process (MESO-PP): An innovative strategy for personalized treatment of Chagas disease.
    Magi MS, Lopez-Vidal L, Rega P, Ibarra M, Palma SD, Jimenez Kairuz A, Real JP.
    Int J Pharm; 2024 Sep 05; 662():124476. PubMed ID: 39029635
    [Abstract] [Full Text] [Related]

  • 7. Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system.
    Fonseca-Berzal C, Palmeiro-Roldán R, Escario JA, Torrado S, Arán VJ, Torrado-Santiago S, Gómez-Barrio A.
    Exp Parasitol; 2015 Feb 05; 149():84-91. PubMed ID: 25583295
    [Abstract] [Full Text] [Related]

  • 8. Tailoring microstructural, drug release properties, and antichagasic efficacy of biocompatible oil-in-water benznidazol-loaded nanoemulsions.
    Streck L, Sarmento VHV, de Menezes RPRPB, Fernandes-Pedrosa MF, Martins AMC, da Silva-Júnior AA.
    Int J Pharm; 2019 Jan 30; 555():36-48. PubMed ID: 30448310
    [Abstract] [Full Text] [Related]

  • 9. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi.
    Guedes-da-Silva FH, Batista DDGJ, Da Silva CF, Pavão BP, Batista MM, Moreira OC, Souza LRQ, Britto C, Rachakonda G, Villalta F, Lepesheva GI, Soeiro MNC.
    ACS Infect Dis; 2019 Mar 08; 5(3):365-371. PubMed ID: 30625275
    [Abstract] [Full Text] [Related]

  • 10. Development of novel benznidazole formulations: physicochemical characterization and in vivo evaluation on parasitemia reduction in Chagas disease.
    Palmeiro-Roldán R, Fonseca-Berzal C, Gómez-Barrio A, Arán VJ, Escario JA, Torrado-Durán S, Torrado-Santiago S.
    Int J Pharm; 2014 Sep 10; 472(1-2):110-7. PubMed ID: 24928135
    [Abstract] [Full Text] [Related]

  • 11. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
    Ferraz LRM, Alves AÉG, Nascimento DDSDS, Amariz IAE, Ferreira AS, Costa SPM, Rolim LA, Lima ÁAN, Rolim Neto PJ.
    Acta Trop; 2018 Sep 10; 185():127-132. PubMed ID: 29452113
    [Abstract] [Full Text] [Related]

  • 12. Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance.
    Simonazzi A, Davies C, Cid AG, Gonzo E, Parada L, Bermúdez JM.
    J Pharm Sci; 2018 Nov 10; 107(11):2829-2836. PubMed ID: 30005984
    [Abstract] [Full Text] [Related]

  • 13. Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
    Figueirêdo CBM, Nadvorny D, Vieira ACQM, Schver GCRM, Soares Sobrinho JL, Rolim Neto PJ, Lee PI, Soares MFR.
    Eur J Pharm Sci; 2018 Jul 01; 119():208-218. PubMed ID: 29679707
    [Abstract] [Full Text] [Related]

  • 14. A Co-blended Locust Bean Gum and Polymethacrylate-NaCMC Matrix to Achieve Zero-Order Release via Hydro-Erosive Modulation.
    Ngwuluka NC, Choonara YE, Kumar P, du Toit LC, Modi G, Pillay V.
    AAPS PharmSciTech; 2015 Dec 01; 16(6):1377-89. PubMed ID: 25956484
    [Abstract] [Full Text] [Related]

  • 15. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
    García MC, Ponce NE, Sanmarco LM, Manzo RH, Jimenez-Kairuz AF, Aoki MP.
    Antimicrob Agents Chemother; 2016 Jun 01; 60(6):3700-8. PubMed ID: 27067322
    [Abstract] [Full Text] [Related]

  • 16. Benznidazole in vitro dissolution release from a pH-sensitive drug delivery system using Zif-8 as a carrier.
    de Moura Ferraz LR, Tabosa AÉGA, da Silva Nascimento DDS, Ferreira AS, Silva JYR, Junior SA, Rolim LA, Rolim-Neto PJ.
    J Mater Sci Mater Med; 2021 May 17; 32(6):59. PubMed ID: 33999312
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of novel formulations for Chagas' disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks.
    Leonardi D, Salomón CJ, Lamas MC, Olivieri AC.
    Int J Pharm; 2009 Feb 09; 367(1-2):140-7. PubMed ID: 18938233
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
    Pereira Camelo SR, Franceschi S, Perez E, Girod Fullana S, Ré MI.
    Drug Dev Ind Pharm; 2016 Feb 09; 42(6):985-97. PubMed ID: 26548427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.